Our domain strategy of developing a comprehensive product portfolio in complex therapeutic segments such as immune-suppressants, anti-virals, high-end antibiotics has attracted marquee partnerships in Regulated markets such as US, UK, Australia and...
The core generic pharma business of Strides is led by IP-driven product licensing and marketing and distribution partnerships across the globe. We have leveraged our expertise in niche, difficult-to-develop and manufacture products to emerge as a...